Radius Care Reports Earnings Growth and 50% Higher Dividend — FY26 Release
Radius Residential Care Limited
Provider claim
Community provider
2026-10-10
Next review: 2027-04-10
New Zealand company portfolio; financial year ended 31 March 2026
Medium confidence
verified
Primary-source research review
Evidence boundary: Four-page issuer release, fully read and visually inspected; commercial primary evidence rather than independent clinical/sector evaluation. It reports audited results without reproducing statements/audit opinion. Separate investor-presentation reconciliation and financial statements were not fully reviewed in this scoped record audit. AFFO/underlying EBITDA are unaudited; care EBITDAR has a same-site partial-year exclusion. Portfolio and occupancy are dated company measures, not present-day vacancy/staffing/clinical guarantees. Karori settlement, villa/care developments and FY2027 growth are original forecasts; later completion is not established here. Belfast purchase/earthworks do not establish an open care home. Home-support claims omit client counts, eligibility, funding and independent outcomes; Luma claims have no comparative clinical proof here. Dividend headline is retained for source identity, without certifying tax calculations or recommending investments. Current NZX original bytes match; migrated issuer archive bytes differ, although all four page-text and rendered-pixel comparisons match. Preserve original PDF/name/category/June 2026 access. Review10 October 2026 is distinct from 13 May release and31 March reporting period. No inferred current roles, service entitlement or investment recommendation.
Short Answer
Four-page May 2026 issuer release on reported care occupancy, adjusted earnings, planned Karori acquisition, new-build care projects and home-support expansion; forecast capacity and promotional service claims require separate verification.
Why it matters
Use period-specific occupancy and portfolio reporting to formulate care-access questions; separate adjusted earnings, acquisition milestones and proposed development from completed capacity and independently evaluated services.
Key Points
- •Release and exchange publication: 13 May 2026 at 08:30 NZST; year ended 31 March 2026. The original is four physical pages, not six (pp. 1–4; exchange payload).
- •Reported annual average occupancy was 94.9%, up 2.1 percentage points on FY2025. It is a company period-average measure, not a current facility vacancy or clinical-quality rate (p. 1).
- •The company reports revenue $202.3 million, profit before tax $14.3 million, net profit after tax $9.5 million and operating cash flow $25.1 million. This release describes audited statements but does not contain the statements/opinion (pp. 1–2).
- •AFFO means Available Funds from Operations: $12.7 million. AFFO and underlying EBITDA of $27.4 million are explicitly unaudited non-GAAP, with reconciliation directed to a separate investor presentation (p. 1 footnotes).
- •Care EBITDAR per bed was reported as $31,100 on a same-site basis, excluding purchased/sold care homes during their first/last partial year; it is not a public funding rate or standard resident charge (p. 1 footnote 3; p. 2).
- •At release, Radius describes 24 care homes: 12 owned and 12 leased, plus retirement living at four sites. Karori was expected to become its 25th care home on 26 May, not already part of the year-end portfolio (p. 4).
Full Summary & Notes
Four-page May 2026 issuer release on reported care occupancy, adjusted earnings, planned Karori acquisition, new-build care projects and home-support expansion; forecast capacity and promotional service claims require separate verification.
Open the full summary for detailed notes and source links.
Radius Residential Care Limited’s four-page release is dated 13 May 2026 and concerns the year ended 31 March 2026. NZX records publication at 08:30 NZST on 13 May; PDF production metadata has the same day. The exchange attachment matches the preserved June 2026 capture byte for byte. The migrated Radius Health archive copy has different bytes, although all four extracted pages and rendered page pixels match; both hashes are retained and the original remains unchanged.
The release reports annual average occupancy of 94.9%, up 2.1 percentage points, revenue of $202.3 million, net profit after tax of $9.5 million and operating cash flow of $25.1 million. Available Funds from Operations of $12.7 million and underlying EBITDA of $27.4 million are explicitly unaudited non-GAAP; reconciliation is located in a separate investor presentation, not this document. Its $31,100 care EBITDAR per bed uses a same-site adjustment excluding acquired/disposed homes in their first/last partial year.
At release the profile describes 24 care homes, 12 owned and 12 leased, with Karori’s 90 beds and 14 units expected to join later in May. It reports the March purchase of Belfast land and early earthworks, an approximately 80-villa staged plan, and proposed care expansion including Hokitika. Matamata and Clare House villa works have FY2027 completion expectations. None of those forward statements is evidence of delivered later capacity.
Home-support and rehabilitation expansion and the Luma continence range are company claims without client counts, funded eligibility, comparative trials or independently demonstrated care outcomes here. Use the release to understand the original operating story and ask targeted questions about staffing, fees, access and delivery. It is not a facility audit, current care directory, proof of completed acquisitions or investment recommendation.
Read bundled source notes
The saved source file may include fuller notes and references than the indexed summary. Check its dates and evidence limits.
Loading saved source notes…
Document Details & Metadata
Related Resources
Historical FY2024 operator report on care occupancy, resident and employee feedback, development, audited financial statements, climate scenarios and governance; underlying profit and care-quality narrative have separate assurance limits.
Two-page issuer results release linking unaudited underlying EBITDA, mixed care-suite/apartment completions and portfolio growth to the year ended March 2026; should be read with the full financial annual report, doc-0194.
The report brings together a corporate portfolio overview, strategy, resident experience, workforce and environmental initiatives, audited consolidated financial statements and remuneration/governance reporting. Its accounts report a statutory loss despite improved adjusted operating earnings and positive aggregate free cash flow; the existing-operations component of that cash flow remains negative. Restated FY25 values and the note 2 reconciliation are essential for comparisons. Use the company’s dated care occupancy and portfolio figures to frame questions, with mature-site and cross-country boundaries retained. Organisation-wide team members are not clinical staffing FTE; NPS and participation scores lack detailed survey denominators. Testimonials, product roll-outs and training claims are commercial narrative rather than independently evaluated clinical evidence. Future construction, demographic assertions and dividend/funding expectations require separate subsequent verification.
Report-based reconciliation of a June 2026 source brief. Original authored publication date is known only to year 2026; 5 June dates the annual report, not necessarily the brief. Detailed narrative retains historical strategy and June news context while correcting report contradictions; analyst reaction, subsequent bond events and later role/project outcomes are not independently checked in this scoped review.
FY2024 care operator report on high-acuity beds, employee and resident feedback, RConnect staffing, community activity, new home-support plans and audited financial results; 49 PDF spreads contain the numbered report through page 95.
Historical FY2025 report covering village and co-located care capacity, mixed unit/suite completions, workforce feedback, development plans, emissions accounting and audited financial statements; portfolio excludes the Palmerston North joint venture.